Publicaciones en las que colabora con José A. Obeso Inchausti (20)

2010

  1. Efficacy and safety of pallidal stimulation in primary dystonia: Results of the Spanish multicentric study

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 81, Núm. 1, pp. 65-69

2005

  1. Erratum: Levodopa in the treatment of Parkinson's disease: Current controversies (Movement Disorders) (2004))

    Movement Disorders

  2. Optimization of use of levodopa in Parkinson's disease: Role of levodopa-carbidopa-entacapone combination

    Neurologia, Vol. 20, Núm. 4, pp. 180-188

2004

  1. Levodopa in the treatment of Parkinson's disease: Current controversies

    Movement Disorders, Vol. 19, Núm. 9, pp. 997-1005

  2. Tratado sobre la enfermedad de Parkinson

    Grupo Luzán 5

1997

  1. Tratado sobre la enfermedad de Parkinson

    Madrid : Luzán 5, 1997

1994

  1. REVIEW: The Role of Pulsatile Versus Continuous Dopamine Receptor Stimulation for Functional Recovery in Parkinson's Disease

    European Journal of Neuroscience, Vol. 6, Núm. 6, pp. 889-897

1992

  1. Differences in the motor response to apomorphine between untreated and fluctuating patients with Parkinson's disease

    Clinical Neuropharmacology, Vol. 15, Núm. 1, pp. 13-18

  2. FLUCTUACIONES MOTORAS EN LA ENFERMEDAD DE PARKINSON: FACTORES DE RIESGO

    Neurologia, Vol. 7, Núm. 5, pp. 89-93

  3. Motor response to repeated dopaminergic stimulation in Parkinson's disease

    Clinical Neuropharmacology, Vol. 15, Núm. 1, pp. 75-79

  4. Time interval between repeated injections conditions the duration of motor improvement to apomorphine in Parkinson’s disease

    Neurology, Vol. 42, Núm. 7, pp. 1287-1290

1989

  1. Clinical and CT scan findings in a case of cyanide intoxication

    Movement Disorders, Vol. 4, Núm. 2, pp. 188-193

  2. Motor complications associated with chronic levodopa therapy in Parkinson's disease

    Neurology

  3. Motor response following repeated apomorphine administration is reduced in Parkinson's disease

    Clinical Neuropharmacology, Vol. 12, Núm. 1, pp. 14-22

  4. Overcoming pharmacokinetic problems in the treatment of parkinson's disease

    Movement Disorders, Vol. 4, Núm. 1 S, pp. S70-S85

1988

  1. Continuous dopaminergic stimulation for Parkinson's disease: Facts and fancy

    Functional Neurology, Vol. 3, Núm. 4, pp. 413-427

  2. Levodopa therapy and motor fluctuations in Parkinson's disease

    Annals of Neurology

1987

  1. APOMORPHINE INFUSION FOR MOTOR FLUCTUATIONS IN PARKINSON'S DISEASE

    The Lancet, Vol. 329, Núm. 8546, pp. 1376-1377

  2. Continuous dopaminergic stimulation in Parkinson's disease

    Canadian Journal of Neurological Sciences, Vol. 14, Núm. 3 SUPPL., pp. 488-492

  3. Estimulación dopaminérgica continua en la enfermedad de Parkinson.

    Neurologia, Vol. 2, Núm. 5, pp. 227-234